Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
9.85
+0.07 (0.72%)
At close: Dec 5, 2025, 4:00 PM EST
9.89
+0.04 (0.41%)
After-hours: Dec 5, 2025, 7:34 PM EST
Telix Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Telix Pharmaceuticals stock ranges from a low of $20 to a high of $22. The average analyst price target of $21 forecasts a 113.20% increase in the stock price over the next year.
Price Target: $21.00 (+113.20%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 23, 2025.
Analyst Ratings
The average analyst rating for Telix Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $23 → $20 | Strong Buy | Maintains | $23 → $20 | +103.05% | Sep 23, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +123.35% | Sep 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 → $20 | Strong Buy | Maintains | $23 → $20 | +103.05% | Sep 10, 2025 |
| Wedbush | Wedbush | Buy Reiterates $22 | Buy | Reiterates | $22 | +123.35% | Aug 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +133.50% | Jul 3, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.